Search research articles
Contact Us
Filters
Showing results (11-20 of 209) with videos related to
Page
of 21
Sort By:
European Urology
|
May 11, 2021
Systemic Therapy for Advanced Non-clear-Cell Renal Cell Carcinoma: Slow but Definite Progress
Daniel M Geynisman, Elizabeth R Plimack
Journal of Oncology Practice
|
May 11, 2017
Bending the Curve of Advanced Urothelial Carcinoma
Daniel M Geynisman, Elizabeth R Plimack
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2016
Targeted Therapy for Metastatic Urothelial Cancer: A Work in Progress
Elizabeth R Plimack, Daniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 16, 2011
Selecting targeted therapies for patients with renal cell carcinoma
Elizabeth R Plimack, Gary R Hudes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2022
Platinum-Free Systemic Therapy in First-Line Metastatic Urothelial Carcinoma: Mirage or Oasis in the Platinum Desert?
Elizabeth R Plimack, Matthew R Zibelman
Annals of Internal Medicine
|
October 27, 2015
Measuring the Efficacy and Value of Urothelial Cancer Urinary Biomarkers
Phillip H Abbosh, Elizabeth R Plimack
Urologic Oncology
|
November 28, 2016
Emerging role of immunotherapy in urothelial carcinoma-Advanced disease
Matthew Zibelman, Chethan Ramamurthy, Elizabeth R Plimack
European Urology
|
November 9, 2021
Placing Adjuvant Chemotherapy in the Evolving Paradigm of Perioperative Therapy for Bladder Cancer
Benjamin Miron, Laura Bukavina, Elizabeth R Plimack
The Journal of Urology
|
September 5, 2025
Editorial Comment
Gregory Hemenway, Elizabeth R Plimack, Daniel M Geynisman
European Urology
|
May 31, 2016
Second-generation Androgen Receptor-targeted Therapies in Nonmetastatic Castration-resistant Prostate Cancer: Effective Early Intervention or Intervening Too Early?
Daniel M Geynisman, Elizabeth R Plimack, Matthew Zibelman
Page
of 21
Search research articles
Search
Showing results (11-20 of 209) with videos related to
Sort By:
Page
of 21
European Urology
|
May 11, 2021
Systemic Therapy for Advanced Non-clear-Cell Renal Cell Carcinoma: Slow but Definite Progress
Daniel M Geynisman, Elizabeth R Plimack
Journal of Oncology Practice
|
May 11, 2017
Bending the Curve of Advanced Urothelial Carcinoma
Daniel M Geynisman, Elizabeth R Plimack
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2016
Targeted Therapy for Metastatic Urothelial Cancer: A Work in Progress
Elizabeth R Plimack, Daniel M Geynisman
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 16, 2011
Selecting targeted therapies for patients with renal cell carcinoma
Elizabeth R Plimack, Gary R Hudes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 7, 2022
Platinum-Free Systemic Therapy in First-Line Metastatic Urothelial Carcinoma: Mirage or Oasis in the Platinum Desert?
Elizabeth R Plimack, Matthew R Zibelman
Annals of Internal Medicine
|
October 27, 2015
Measuring the Efficacy and Value of Urothelial Cancer Urinary Biomarkers
Phillip H Abbosh, Elizabeth R Plimack
Urologic Oncology
|
November 28, 2016
Emerging role of immunotherapy in urothelial carcinoma-Advanced disease
Matthew Zibelman, Chethan Ramamurthy, Elizabeth R Plimack
European Urology
|
November 9, 2021
Placing Adjuvant Chemotherapy in the Evolving Paradigm of Perioperative Therapy for Bladder Cancer
Benjamin Miron, Laura Bukavina, Elizabeth R Plimack
The Journal of Urology
|
September 5, 2025
Editorial Comment
Gregory Hemenway, Elizabeth R Plimack, Daniel M Geynisman
European Urology
|
May 31, 2016
Second-generation Androgen Receptor-targeted Therapies in Nonmetastatic Castration-resistant Prostate Cancer: Effective Early Intervention or Intervening Too Early?
Daniel M Geynisman, Elizabeth R Plimack, Matthew Zibelman
Page
of 21